(Q43198291)

English

Long-term disease-free survival after nonmyeloablative cyclophosphamide/fludarabine conditioning and related/unrelated allotransplantation for acute myeloid leukemia/myelodysplasia

scientific article published on 11 January 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Long-term disease-free survival after nonmyeloablative cyclophosphamide/fludarabine conditioning and related/unrelated allotransplantation for acute myeloid leukemia/myelodysplasia (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

1 reference

based on heuristic

inferred from title

author name string

R P Nelson

1

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

M Yu

2

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

J E Schwartz

3

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

M J Robertson

4

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

R Hromas

5

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

C A Fausel

6

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

G H Vance

7

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

S R Dlouhy

8

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

J A Baute

9

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

E A Cox

10

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

L L Wood

11

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

S Srivastava

12

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

K A Robertson

13

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

P R Haut

14

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

S S Farag

15

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

R Abonour

16

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

K Cornetta

17

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

L D Cripe

18

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

language of work or name

0 references

publication date

11 January 2010

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

45

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

1300-1308

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

https://scigraph.springernature.com/pub.10.1038/bmt.2009.348

0 references

Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective s

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.348

21 January 2018

Myeloablative vs nonmyeloablative allogeneic transplantation for patients with myelodysplastic syndrome or acute myelogenous leukemia with multilineage dysplasia: a retrospective analysis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.348

21 January 2018

Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: the role of dose intensity

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.348

21 January 2018

Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes and acute myelogenous leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.348

21 January 2018

Serious graft-versus-host disease after hematopoietic cell transplantation following nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.348

21 January 2018

Reduced-intensity conditioning for acute myeloid leukemia: is this strategy correct

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.348

21 January 2018

Second EBMT Workshop on reduced intensity allogeneic hemopoietic stem cell transplants (RI-HSCT).

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.348

21 January 2018

Allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning as treatment for hematologic malignancies and inherited blood disorders

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.348

21 January 2018

Variable number of tandem repeat (VNTR) markers for human gene mapping

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.348

21 January 2018

Acute and chronic graft-versus-host disease in man.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.348

21 January 2018

Chronic graft-versus-host disease: clinical features and grading systems

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.348

21 January 2018

Thrombotic microangiopathy after allogeneic stem cell transplantation in the era of reduced-intensity conditioning: The incidence is not reduced

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.348

21 January 2018

Skin cancer after nonmyeloablative hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.348

21 January 2018

Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.348

21 January 2018

Maintenance of remission in acute myeloid leukemia by allogeneic or autologous bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.348

21 January 2018

Effect of slow lymphocyte recovery and type of graft-versus-host disease prophylaxis on relapse after allogeneic bone marrow transplantation for acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.348

21 January 2018

Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.348

21 January 2018

Influence of cytogenetic abnormalities on outcome after allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.348

21 January 2018

The graft-versus-leukemia effect of nonmyeloablative stem cell allografts may not be sufficient to cure chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.348

21 January 2018

Comparable non-relapse mortality and survival after HLA-identical sibling blood stem cell transplantation with reduced or conventional-intensity preparative regimens for high-risk myelodysplasia or acute myeloid leukemia in first remission.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.348

21 January 2018

Control of advanced and refractory acute myelogenous leukaemia with sirolimus-based non-myeloablative allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.348

21 January 2018

Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.348

21 January 2018

Allogeneic hematopoietic stem cell transplantation for the treatment of high-risk acute myelogenous leukemia and myelodysplastic syndrome using reduced-intensity conditioning with fludarabine and melphalan

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.348

21 January 2018

Allogeneic stem-cell transplantation using a reduced-intensity conditioning regimen has the capacity to produce durable remissions and long-term disease-free survival in patients with high-risk acute myeloid leukemia and myelodysplasia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.348

21 January 2018

Dysregulation of cytokines during graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.348

21 January 2018

Inflammatory cytokines and dendritic cells in acute graft-versus-host disease after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.348

21 January 2018

Mycophenolate mofetil and cyclosporine for graft-versus-host disease prophylaxis following reduced intensity conditioning allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.348

21 January 2018

Elimination of graft-versus-host disease by in-vitro depletion of alloreactive lymphocytes with a monoclonal rat anti-human lymphocyte antibody (CAMPATH-1).

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.348

21 January 2018

Therapeutic approaches for transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.348

21 January 2018

Anti-CD25 monoclonal antibody (basiliximab) for prevention of graft-versus-host disease after haploidentical bone marrow transplantation for hematological malignancies

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.348

21 January 2018

Pharmacokinetics of intravenous mycophenolate mofetil after allogeneic blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.348

21 January 2018

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.348

7 January 2021

based on heuristic

inferred from DOI database lookup

Fludarabine-based non-myeloablative chemotherapy followed by infusion of HLA-identical stem cells for relapsed leukaemia and lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.348

7 January 2021

based on heuristic

inferred from DOI database lookup

Mixed hematopoietic chimerism after hematopoietic stem cell allografts

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.348

7 January 2021

based on heuristic

inferred from DOI database lookup

Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.348

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.348

7 January 2021

based on heuristic

inferred from DOI database lookup

The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.348

7 January 2021

based on heuristic

inferred from DOI database lookup

National Marrow Donor Program HLA-matching guidelines for unrelated marrow transplants

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.348

7 January 2021

based on heuristic

inferred from DOI database lookup

Large-scale mobilization and isolation of CD34+ cells from normal donors

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.348

7 January 2021

based on heuristic

inferred from DOI database lookup

A Prospective Multicenter Trial of Peripheral Blood Stem Cell Sibling Allografts for Acute Myeloid Leukemia in First Complete Remission Using Fludarabine-Cyclophosphamide Reduced Intensity Conditioning

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.348

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors in adult de novo myelodysplastic syndromes treated by intensive chemotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.348

7 January 2021

based on heuristic

inferred from DOI database lookup

Early allogeneic transplantation favorably influences the outcome of adult patients suffering from acute myeloid leukemia. Société Française de Greffe de Moelle (SFGM)

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.348

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term remissions in patients with myelodysplastic syndrome and secondary acute myelogenous leukemia undergoing allogeneic transplantation following a reduced intensity conditioning regimen of 550 cGy total body irradiation and cyclophosphamide

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.348

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term survival of skin allografts in mice treated with fractionated total lymphoid irradiation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.348

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanisms of suppression in mixed allogeneic chimeras

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.348

7 January 2021

based on heuristic

inferred from DOI database lookup

Inflammatory cytokines and acute graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.348

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/BMT.2009.348

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Dimensions Publication ID

0 references

release_2u2dmpqmandonhgjq77pp7jtvq

1 reference

https://api.fatcat.wiki/v0/release/2u2dmpqmandonhgjq77pp7jtvq

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43198291&oldid=1983625358"